Edgewise Therapeutics, Inc. Operating Leases, Rent Expense
Edgewise Therapeutics, Inc. (EWTX) reported Operating Leases, Rent Expense of $22.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-05-13
- Edgewise Therapeutics, Inc. operating leases, rent expense for the quarter ending 2021-03-31 was $22.00K, a 29.41% increase year-over-year.
- Edgewise Therapeutics, Inc. operating leases, rent expense for the quarter ending 2020-03-31 was $17.00K.
| Period end | Operating Leases, Rent Expense 3 month |
|---|---|
| 2021-03-31 | $22.00K 10-Q · filed 2021-05-13 |
| 2020-03-31 | $17.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 |